Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
AK Medical Holdings Ltd. ( (HK:1789) ) just unveiled an announcement.
AK Medical Holdings Limited has announced its intention to conduct on-market share repurchases of up to 10% of its issued share capital, capped at HK$150 million, under a general mandate granted at its 18 June 2025 annual general meeting. The buyback, to be executed on the Hong Kong Stock Exchange and funded entirely by internal resources, will see all repurchased shares cancelled, and is framed by the board as a signal of confidence in the group’s business outlook and financial strength, while the company stresses that the actual scale and timing of purchases will depend on market conditions and will comply with all relevant Hong Kong and Cayman Islands regulations, without jeopardizing the required public float.
The most recent analyst rating on (HK:1789) stock is a Buy with a HK$6.50 price target. To see the full list of analyst forecasts on AK Medical Holdings Ltd. stock, see the HK:1789 Stock Forecast page.
More about AK Medical Holdings Ltd.
AK Medical Holdings Limited is a Cayman Islands-incorporated company listed on the Hong Kong Stock Exchange. Through its group subsidiaries, it operates in the medical sector, with its shares traded under stock code 1789, and maintains a shareholder base that includes both public investors and institutional stakeholders.
Average Trading Volume: 3,197,469
Technical Sentiment Signal: Hold
Current Market Cap: HK$6.55B
For detailed information about 1789 stock, go to TipRanks’ Stock Analysis page.